| |
| About AT |
| |
| AT™ setup a subsidiary in China specifically to fill the market need for a high quality supplier of microarray services and solutions to the China biochip market. |
| |
| AT™ recognizes a growing need in the global market for quality microarray outsourcing for gene expression, genotyping and resequencing analysis. AT™ also is an active participant in the movement towards "Individualized Medicine" in the industry, made possible by high throughput genomics. |
| |
| AT™ services include: |
- experimental design consultation
- biological sample preparation
- sample processing
- data/statistical analysis services
|
| |
| AT™ uses and has established quality and regulatory standards for all its microarray processing, analysis and data management. AT™ has implemented auditable Standard Operating Procedure (SOP) to help minimize variability and is compliant with 21 CFR Part 58 (Good Laboratory Practices) and 21 CFR Part 11 (Electronic Records and Signatures). |
| |
| AT™ is working with the State Drug Administration of China (SDA) to develop a format for electronic submission of microarray-based gene expression data and associated results in China. The outcome of this work will be intended towards the establishment of regulatory initiatives using genomic data to accelerate drugs and diagnostics through the SDA. |
| |
| |
